Cooperation between AlphavBeta3 integrin and the fibroblast growth factor receptor enhances proliferation of Hoxoverexpressing acute myeloid leukemia cells

Oncotarget

Volumn 7, Issue 34, 2016, Pages 54782-54794

  Shah, Chirag A ^a   Bei, Ling ^a,b   Wang, Hao ^a   Altman, Jessica K ^a   Platanias, Leonidas C ^a,b   Eklund, Elizabeth A ^a,b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b JESSE BROWN VA MEDICAL CENTER   (United States)

Author keywords

Fibroblast growth factor; Homeobox; Integrin; Leukemia; Myeloid cell; Transcription factor

Indexed keywords

BETA CATENIN; CD34 ANTIGEN; FIBROBLAST GROWTH FACTOR RECEPTOR; PROTEIN KINASE SYK; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR CDX4; TRANSCRIPTION FACTOR HOXA10; TRANSCRIPTION FACTOR HOXA9; UNCLASSIFIED DRUG; VITRONECTIN RECEPTOR; HOMEODOMAIN PROTEIN; MIXED LINEAGE LEUKEMIA PROTEIN; MLL-ELL FUSION PROTEIN, HUMAN; ONCOPROTEIN;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; GENE; GENE FUNCTION; GENE IDENTIFICATION; GENE INTERACTION; HUMAN; HUMAN CELL; ITGB3 GENE; MOLECULAR CLONING; MOUSE; NONHUMAN; PROMOTER REGION; PROTEIN FUNCTION; PROTEIN INTERACTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; STEM CELL; ACUTE DISEASE; ANIMAL; C57BL MOUSE; CELL CULTURE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MYELOID LEUKEMIA; MYELOID PROGENITOR CELL; PATHOLOGY; RNA INTERFERENCE; U-937 CELL LINE;

ACUTE DISEASE; ANIMALS; CELL PROLIFERATION; CELLS, CULTURED; GENE EXPRESSION REGULATION, LEUKEMIC; HOMEODOMAIN PROTEINS; HUMANS; INTEGRIN ALPHAVBETA3; LEUKEMIA, MYELOID; MICE, INBRED C57BL; MYELOID PROGENITOR CELLS; MYELOID-LYMPHOID LEUKEMIA PROTEIN; ONCOGENE PROTEINS, FUSION; PROMOTER REGIONS, GENETIC; RECEPTORS, FIBROBLAST GROWTH FACTOR; RNA INTERFERENCE; U937 CELLS;

EID: 84983541835     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.10189     Document Type: Article

References (43)

1. Acampora D, D'Esposito M, Faiella A, Pannese M, Migliaccio E, Morelli F, Stornaiuolo A, Nitro V, Simeone A, Boncinelli A. The human HOX gene family. Nucleic Acids Res. 1989; 17: 10385-10400.
2. Sauvageau G, Lansdorp PM, Eaves CJ, Hogge DE, Dragowska WH, Reid DS, Largman C. Differential expression of homeobox genes in functionally distinct CD34+ subpopulations of human bone marrow cells. Proc. Natl. Acad. Sci. USA. 1994; 91: 12223-7.
3. Satokata I, Benson G, Maas R. Sexually dimorphic sterility phenotypes in Hoxa10-deficient mice. Nature. 1995; 374: 460-3.
4. Lawrence HJ, Helgason CD, Sauvageau G, Fong S, Izon DJ, Humphries RK, Largman C. Mice bearing a targeted interruption of the homeobox gene HOXA9 have defects in myeloid, erythroid, and lymphoid hematopoiesis. Blood. 1995; 89: 1922-30
5. Lawrence HJ, Christensen J, Fong S, Hu YL, Weissman I, Sauvageau G, Humphries RK, Largman, C. Loss of expression of the Hoxa-9 homeobox gene impairs the proliferation and repopulating ability of hematopoietic stem cells. Blood. 2005; 106: 3988-94
6. Wang H. Bei L, Shah CA, Hu L, Eklund EA. HoxA10 Terminates Emergency Granulopoiesis by Increasing Expression of Triad1. J Immunol. 2015; 194: 5375-87.
7. Kawagoe H, Humphries RK, Blair A, Sutherland HJ, Hogge DE. Expression of HOX genes, HOX cofactors, and MLL in phenotypically and functionally defined subpopulations of leukemic and normal human hematopoietic cells. Leukemia. 1999; 13: 687-98.
8. Calvo KR, Sykes DB, Pasillas M, Kamps MP. Hoxa9 immortalizes a granulocyte-macrophage colony-stimulating factor-dependent promyelocyte capable of biphenotypic differentiation to neutrophils or macrophages, independent of enforced meis expression. Mol. Cell. Biol. 2000; 20: 3274-85.
9. Buske C, Feuring-Buske M, Antonchuk J, Rosten P, Hogge DE, Eaves CJ, Humphries RK. Overexpression of HOXA10 perturbs human lymphomyelopoiesis in vitro and in vivo. Blood. 2001; 97: 2286-92.
10. Thorsteinsdottir U, Mamo A, Kroon E, Jerome L, Bijl J, Lawrence HJ, Humphries K, Sauvageau G. Overexpression of the myeloid leukemia-associated Hoxa9 gene in bone marrow cells induces stem cell expansion. Blood. 2002; 99: 121-9.
11. Wang H, Lindsey S, Konieczna I, Bei L, Horvath E, Huang W, Saberwal G, Eklund EA. Constitutively active SHP2 cooperates with HoxA10 overexpression to induce acute myeloid leukemia. J. Biol. Chem. 2009; 284: 2549-67
12. Bjornsson JM, Andersson E, Lundstrom P, Larsson N, Xu X, Repetowska E, Humpthries KR, Karlsson S. Proliferation of primitive myeloid progenitors can be reversibly induced by HOXA10. Blood. 2001; 98: 3301-8.
13. Kroon E, Krosl J, Thorsteinsdottir U, Baban S, Buchberg AM, Sauvageau G. Hoxa9 transforms primary bone marrow cells through specific collaboration with Meis1a but not Pbx1b. EMBO J. 1998; 17: 3714-25.
14. Guenther MG, Jenner RG, Chevalier B, Nakamura T, Croce CM, Canaani E, Young RA. Global and Hox-specific roles for the MLL1 methyltransferase. Proc. Natl. Acad. Sci. USA. 2005; 102: 8603-8.
15. Milne TA, Briggs SD, Brock HW, Martin ME, Gibbs D, Allis CD, Hess JL. MLL targets SET domain methyltransferase activity to Hox gene promoters. Mol. Cell. 2002; 10: 1107-17.
16. Ernst P, Mabon M, Davidson AJ, Zon LI, Korsmeyer SJ. An Mll-dependent Hox program drives hematopoietic progenitor expansion. Current. Biol. 2004; 14: 2063-9.
17. Camos M, Esteve J, Jares P, Colomer D, Rozman M, Villamor N, Costa D, Carrio A, Nomdedue J, Montserrat E, Campo E. Gene expression profiling of acute myeloid leukemia with translocation t(8;16)(p11;p13) and MYST3-CREBBP rearrangement reveals a distinctive signature with a specific pattern of HOX gene expression. Cancer Res. 2006; 66: 6947-54.
18. Riche J, Zeng C, Baron A, Gadgil S, Gemmill RM, Tigaud I, Thomas X, Drabkin HA. Hox expression in AML identified a distinct subset of patients with intermediate cytogenetics. Leukemia. 2004; 18: 1059-63.
19. Li Z, Luo RT, Mi S, Sun M, Chen P, Bao J, Neilly MB, Jayathilaka N, Johnson DS, Wang, L, Lavau C, Zhang Y, Tseng C, Zhang X, Wang J, Yu J, Yang H, Wang SM, Rowley JD, Chen J, Thirman MJ. Consistent deregulation of gene expression between human and murine MLL rearrangement leukemias. Cancer Res. 2009; 69: 1109-16
20. Daigle SR, Olhava EJ, Therkelsen CA, Majer CR, Sneeringer CJ, Song J, Johnston LD, Scott MP, Smith JJ, Xiao Y, Jin L, Kuntz KW, Chesworth R, et. al. Selective killing of mixed lineage leukemia cells by a potent smallmolecule DOT1L inhibitor. Cancer Cell. 2011; 20: 53-65
21. Deshpande AJ, Chen L, Fazio M, Sinha AU, Bernt KM, Banka D, Dias S, Chang J, Olhava EJ, Daigle SR, Richon VM, Pollock RM, Armstrong SA. Leukemic transformation by the MLL-AF6 fusion oncogene requires the H3K79 methyltransferase Dot1l. Blood. 2013; 121: 2533-41.
22. Shah CA, Bei L, Wang H, Platanias LC, Eklund EA. HoxA10 regulates transcription of the gene encoding Fibroblast Growth Factor 2 (FGF2) in myeloid cells. J Biol Chem. 2012; 287: 18230-48
23. Shah CA, Wang H, Bei L, Platanias LC, Eklund EA. HoxA10 regulates transcription of the gene encoding transforming growth factor beta 2 (TGFB2) in myeloid cells. J. Biol. Chem. 2011; 286: 3161-76
24. Eklund EA, Jalava A, Kakar R. Tyrosine phosphorylation decreases HoxA10 DNA-binding and transcriptional repression during IFNγ differentiation in myeloid cell lines. J. Biol. Chem. 2000; 275: 20117-26.
25. Lindsay S, Huang W, Wang H, Horvath E, Zhu C, Eklund EA. Activation of SHP2 protein-tyrosine phosphatase increases HoxA10-induced repression of the genes encoding gp91PHOX and p67PHOX. J. Biol. Chem. 2007; 282: 2237-49
26. Bei L, Lu YF, Eklund EA. HoxA9 activates transcription of the gene encoding gp91PHOX during myeloid differentiation. J. Biol. Chem. 2005; 280: 12359-70
27. Wang H, Bei L, Shah CA, Horvath E, Eklund, EA. HoxA10 influences protein ubiquitination by activating transcription of ARIH2; the gene encoding Triad1l J. Biol. Chem. 2011; 286: 16832-45.
28. Bei L, Huang W, Wang H, Shah C, Horvath E, Eklund EA. HoxA10 activates CDX4 transcription and Cdx4 activates HOXA10 transcription in myeloid cells. J. Biol. Chem. 2011; 286: 19047-64.
29. Bei L, Shah C, Wang H, Huang W, Roy R, Eklund EA. Beta Catenin Activates the HOXA10 and CDX4 Genes in Myeloid Progenitor Cells. J. Biol. Chem. 2012; 287: 39589-601
30. Bei L, Shah C, Wang H, Huang W, Platanias LC, Eklund EA. Regulation of CDX4 gene transcription by HoxA9, HoxA10, the Mll-Ell oncogene and Shp2 during leukemogenesis. Oncogenesis. 2014; 3:e135
31. Kim JJ, Taylor HS, Lu Z, Ladhani O, Hastings JM, Jackson KS, Wu Y, Guo SW, Fazleabas AT. Altered expression of HOXA10 in endometriosis: potential role in decidualization. Mol Hum Reprod. 2007; 13: 323-32
32. Bei L, Lu YF, Bellis SL, Zhou W, Horvath E, Eklund EA. Identification of a HoxA10 activation domain necessary for transcription of the gene encoding beta3 integrin during myeloid differentiation. J. Biol. Chem. 2007; 282: 16846-59
33. Butler B, Williams MP, Blystone SD. Ligand-dependent activation of integrin alphavbeta3. J. Biol. Chem. 2003; 278: 5264-70
34. Miranti CK, Leng L, Maschberger P, Brugge JS, Shattil SJ. Identification of a novel integrin signaling pathway involving the kinase Syk and the guanine nucleotide exchange factor Vav1. Curr. Biol. 1998; 3: 1289-99.
35. Shah CA, Bei L, Wang H, Platanias LC, Eklund EA. The leukemia-associated Mll-Ell oncoprotein induces Fibroblast growth factor 2 (Fgf2)-dependent cytokine hypersensitivity in myeloid progenitor cells. J. Biol. Chem. 2013; 288: 32490-505
36. Murakami M, Elfenbein A, Simons M. Non-canonical fibroblast growth factor signaling in angiogenesis. Cardiovascular Res. 2008; 78: 223-31
37. Lowney P, Corral J, Detmer K, Le Beau MM, Deaven L, Lawrence HJ, Largman C. A human Hox 1 homeobox gene exhibits myeloid-specific expression of alternative transcripts in human hematopoietic cells. Nucl. Acids Res. 1991; 19: 3443-3449
38. Wang H, Lu YF, Huang W, Papoutsakis ET, Fuhrken P, Eklund EA. HoxA10 activates transcription of the gene encoding mitogen-activated protein kinase phosphatase 2 (Mkp2) in myeloid cells. J. Biol. Chem. 2007; 282: 16164-76
39. Larrick JW, Fischer DG, Anderson SJ, Koren HA. Characterization of a human macrophage-like cell line stimulated in vitro: a model of macrophage functions. J. Immunol. 1980; 125: 6-12.
40. Oberley MJ, Farnham PJ. Probing chromatin immunoprecipitates with CpG-island microarrays to identify genomic sites occupied by DNA-binding proteins. Methods in Enzymol. 2003; 371: 577-596
41. Roberts M, Barry S, Woods A, van der Sluijs P, Norman J. PDGF-regulated rab4-dependent recycling of alphavbeta3 integrin from early endosomes is necessary for cell adhesion and spreading. Curr. Biol. 2001; 11: 1392-402
42. Thomas M, Felcht M, Kruse K, Kretschme S, Deppermann C, Biesdorf A, Rohr K, Benest AV, Fiedler U, Augustin HG. Angiopoietin-2 stimulation of endothelial cells induces alphavbeta3 integrin internalization and degradation. J. Biol. Chem. 2010; 285: 23842-9
43. Miller PG, Al-Shahrour F, Hartwell KA, Chu LP, Järås M, Puram RV, Puissant A, Callahan KP, Ashton J, McConkey ME, Poveromo LP, Cowley GS, Kharas MG, et. al. In Vivo RNAi screening identifies a leukemia-specific dependence on integrin beta 3 signaling. Cancer Cell. 2013; 24: 45-58